attachment

<html> <head> <meta http-equiv="Content-Type" content="text/html; charset=windows-1252"> <meta name="GENERATOR" content="Microsoft FrontPage 4.0"> <meta name="ProgId" content="FrontPage.Editor.Document"> <title></title> </head> <body bgcolor="#CCCCCC"> <div align="center"> <table border="2" width="550" cellpadding="14" cellspacing="5" bordercolor="#003366" bordercolorlight="#003366" bordercolordark="#003366"> <tr> <td width="100%" bgcolor="#FFFFFF"> Help Beta Test Our Site and Be Eligible to Purchase Shares of Future IPOs In Which We Participate** eMedsecurities has selected you as a possible participant to help test our online stock-trading engine for knowledge-based investing in the life sciences. For your cooperation, you will be eligible to purchase shares of future IPOs in which we participate, for as long as you maintain your account with us. This is limited to only 50 qualified testers!  <a href="mailto:emedsec@libero.it">Request More Information</a>.** eMedsecurities� The Cure for the Common Portfolio! eMedsecurities provides you with a wealth of information, all compiled in a single, easy-to-use resource.  Learn about new research and upcoming treatments for muscular dystrophy, multiple sclerosis, Parkinson's disease, Huntington's chorea and much more.  Obtain critical investment information about the companies that are developing these treatments.  eMedsecurities empowers you to make more informed investment decisions. <a href="mailto:emedsec@libero.it">Request More Information</a>.** Participation in eMedsecurities� Beta Test allows you: <ul> <li> Eligibility to purchase shares of IPOs in which eMedsecurities participates for as long as you maintain your account**</li> <li> Valuable research of the entire product pipeline of companies, including stages of clinical development, by industry or specific disease</li> <li> Useful information about industry trends, recent developments and upcoming IPOs </li> <li> Commitment to customer service featuring our Live Customer Service Online</li> <li> Dedication to fast trade executions at the best possible price.</li> </ul> The following guidelines will explain what we expect from an eMedsecurities Beta Tester: <ul> <li> Open a funded eMedsecurities account</li> <li> Visit our online trading site once a week</li> <li> Execute trades through our web site in accordance with your normal practice</li> <li> Submit feedback to eMedsecurities' development team through a questionnaire sent via email</li> <li> Provide us with additional feedback regarding the site as needed.</li> </ul> The test is limited to only 50 Beta Testers so sign up now to be considered!  <a href="mailto:emedsec@libero.it">Request More Information</a>.** Please note:  All applications for the Beta Test must be submitted by January 24, 2001 to be considered. Please be advised that your information will stay in our proprietary database and will not be sold, traded, given or otherwise provided to outside vendors.  We respect your privacy.   By submitting your information, you implicitly state that this is something that interests you and that you agree to receive periodic emails from eMedsecurities. Research indicated that you might benefit from our offer.  To be removed instantly and permanently from our database, simply <a href="mailto:emed11@libero.it">click here</a>.  We respect all removal requests. ** Restrictions Apply:  Beta test not open to residents of:  HI, IL, MI, MN, MS, NE, NH, TN, TX.   Initial Public Offerings are considered speculative investments and as such may not be appropriate for every investor. If an investor chooses to participate in IPOs, there are certain restrictions that apply:  Flipping- The first time an investor sells his/her shares within the first 30 days the issue is trading in the secondary market, that investor will not be allocated shares for the next 90 days following the sale.  The second time that investor �flips�, they will not be allocated IPO shares for 180 days.  The third time that investor �flips�, they lose their IPO allocations permanently.  Transferring shares- If the investor transfers IPO shares out of their account within the first 30 days the issue is trading in the secondary market, they will permanently lose their IPO allocations.  Beta investors will be chosen from all the applicants based on their income, net worth and investing experience.  IPO shares will only be allocated from transactions in which eMedsecurities participates in the underwriting. A0008-1-A2 </td> </tr> </table> </div> </body> </html>